Model of translational cancer research in multiple myeloma

Recently, intensive laboratory and preclinical studies have identified and validated therapeutic molecular targets in multiple myeloma (MM). The introduction of novel agents such as the proteasome inhibitor bortezomib and the immunomodulatory drugs thalidomide and lenalidomide, which were rapidly tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasui, Hiroshi, Ishida, Tadao, Maruyama, Reo, Nojima, Masanori, Ikeda, Hiroshi, Suzuki, Hiromu, Hayashi, Toshiaki, Shinomura, Yasuhisa, Imai, Kohzoh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533800/
https://www.ncbi.nlm.nih.gov/pubmed/22809142
http://dx.doi.org/10.1111/j.1349-7006.2012.02384.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533800/
https://www.ncbi.nlm.nih.gov/pubmed/22809142
http://dx.doi.org/10.1111/j.1349-7006.2012.02384.x

Ejemplares similares